Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?: Evidences, unresolved questions and a practical algorithm.

Pons-Tostivint, E; Alouani, E; Kirova, Y; Dalenc, F; Vaysse, C

Pons-Tostivint, E; Alouani, E; Kirova, Y; Dalenc, F; Vaysse, C.

Afiliação

Pons-Tostivint E; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France. Electronic address: elvire.pons-tostivint@inserm.fr.
Alouani E; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.
Kirova Y; Department of Radiation Therapy, Institut Curie, Paris, France.
Dalenc F; Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.
Vaysse C; Surgical Department, Toulouse University Hospital Center (CHU Toulouse), IUCT-Oncopole, 31000, Toulouse, France.

Crit Rev Oncol Hematol ; 157: 103146, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33227574

Assuntos

Neoplasias da Mama; Algoritmos; Neoplasias da Mama/terapia; Humanos; Estudos Prospectivos; Estudos Retrospectivos; Taxa de Sobrevida

Palavras-chave

De novo metastatic breast cancer; Exclusive radiotherapy; Locoregional treatment; Primary tumor; Surgery; Tumor biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google